Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | PRNP | P04156 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3911691 | 0.98 | KIF11 (0.42) | KIF11MEN1KMT2ANPC1POLB | |
| SCHEMBL17917218 | 0.91 | ALDH1A1 (0.39) | KIF11ALDH1A1CYP2A6TDP1MAPK1 | |
| SCHEMBL23366571 | 0.91 | HPRT1 (0.52) | MEN1KMT2ANPC1MAOACYP2D6 | |
| SCHEMBL23366562 | 0.91 | HPRT1 (0.52) | MEN1KMT2ANPC1MAOACYP2D6 | |
| SCHEMBL8840916 | 0.86 | KIF11 (0.54) | KIF11MEN1KMT2ANPC1POLB | |
| SCHEMBL17180585 | 0.86 | KIF11 (0.54) | KIF11MEN1KMT2ANPC1POLB | |
| SCHEMBL349252 | 0.83 | ALDH1A1 (0.43) | MEN1KMT2ACYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL31533202 | 0.83 | ALDH1A1 (0.43) | MEN1KMT2ACYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL29558067 | 0.83 | ALDH1A1 (0.43) | MEN1KMT2ACYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL24871117 | 0.83 | MAPK1 (0.48) | KIF11MEN1KMT2ANPC1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9260657-B2 | Chrysene compounds for luminescent applications | E I DU PONT DE NEMOURS AND COMPANY (US) | 2016-02-16 | — | — | US | disclosed |
| EP-2671936-B1 | Chrysene compounds for luminescent applications | DU PONT (US) | 2015-06-24 | — | — | EP | disclosed |
| EP-2432849-B1 | CHRYSENE COMPOUNDS FOR LUMINESCENT APPLICATIONS | DU PONT (US) | 2015-02-25 | — | — | EP | disclosed |
| EP-2432849-B1 | CHRYSENE COMPOUNDS FOR LUMINESCENT APPLICATIONS | DU PONT (US) | 2015-02-25 | — | — | EP | disclosed |
| EP-2674469-A1 | Chrysene compounds for luminescent applications | E. I. du Pont de Nemours and Company (US) | 2013-12-18 | — | — | EP | disclosed |
| EP-2671936-A1 | Chrysene compounds for luminescent applications | E. I. du Pont de Nemours and Company (US) | 2013-12-11 | — | — | EP | disclosed |
| EP-2669351-A1 | Chrysene compounds for luminescent applications | E. I. du Pont de Nemours and Company (US) | 2013-12-04 | — | — | EP | disclosed |
| US-20120037898-A1 | CHRYSENE COMPOUNDS FOR LUMINESCENT APPLICATIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-02-16 | — | — | US | disclosed |
| US-20120037898-A1 | CHRYSENE COMPOUNDS FOR LUMINESCENT APPLICATIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-02-16 | — | — | US | disclosed |
| US-20120037898-A1 | CHRYSENE COMPOUNDS FOR LUMINESCENT APPLICATIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-02-16 | — | — | US | disclosed |
| US-20110215715-A1 | CHRYSENE COMPOUNDS FOR BLUE OR GREEN LUMINESCENT APPLICATIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-09-08 | — | — | US | disclosed |
| US-20110215715-A1 | CHRYSENE COMPOUNDS FOR BLUE OR GREEN LUMINESCENT APPLICATIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-09-08 | — | — | US | disclosed |
| WO-2010135403-A2 | CHRYSENE COMPOUNDS FOR LUMINESCENT APPLICATIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-11-25 | — | — | WO | disclosed |
| WO-2010059837-A2 | CHRYSENE COMPOUNDS FOR BLUE OR GREEN LUMINESCENT APPLICATIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110215715-A1 | CHRYSENE COMPOUNDS FOR BLUE OR GREEN LUMINESCENT APPLICATIONS | CRY2, CRY1, CYBA | KIF11 2895/4885MEN1 408/4885KMT2A 3179/4885 |
| US-20120037898-A1 | CHRYSENE COMPOUNDS FOR LUMINESCENT APPLICATIONS | CRY2, CENPE, CRY1 | KIF11 3228/4885MEN1 269/4885KMT2A 2555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.